VEGFA and glioblastoma: Steroid-sparing treatments for peritumoral edema that target the vascular endothelial growth factor-A (VEGF-A) pathway are standard-of-care agents in progressive glioblastoma (14) and under clinical development in patients with MBM with concerns about safety and efficacy (clinicaltrials.gov NCT02681549).